|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000111142 |
Summary for METAP2 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000111142 | Gene symbol | METAP2 |
| Gene name | methionyl aminopeptidase 2 | |
| HGNC | 16672 | |
| Entrez ID | 10988 | |
| Gene type | protein_coding | |
| Synonyms | METAP2|MNPEP|p67|MAP2 | |
| UniProtAcc | P50579 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| ENSG00000111142 | MAP2 | DB01196 | Estramustine | SmallMoleculeDrug |
| ENSG00000111142 | MAP2 | DB01229 | Paclitaxel | SmallMoleculeDrug |
| ENSG00000111142 | MAP2 | DB01248 | Docetaxel | SmallMoleculeDrug |
| ENSG00000111142 | METAP2 | DB00134 | Methionine | SmallMoleculeDrug |
| ENSG00000111142 | METAP2 | DB01422 | Nitroxoline | SmallMoleculeDrug |
| ENSG00000111142 | METAP2 | DB02310 | 3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium | SmallMoleculeDrug |
| ENSG00000111142 | METAP2 | DB02640 | Fumagillin | SmallMoleculeDrug |
| ENSG00000111142 | METAP2 | DB02893 | D-Methionine | SmallMoleculeDrug |
| ENSG00000111142 | METAP2 | DB03086 | N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide | SmallMoleculeDrug |
| ENSG00000111142 | METAP2 | DB03396 | (2R,3R,4S,5R,6E)-3,4,5-Trihydroxy-N-[(3S,6R)-6-hydroxy-2-oxo-3-azepanyl]-2-methoxy-8,8-dimethyl-6-nonenamide | SmallMoleculeDrug |
| ENSG00000111142 | METAP2 | DB03900 | tert-butanol | SmallMoleculeDrug |
| ENSG00000111142 | METAP2 | DB04108 | (2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide | SmallMoleculeDrug |
| ENSG00000111142 | METAP2 | DB04324 | Ovalicin | SmallMoleculeDrug |
| ENSG00000111142 | METAP2 | DB05864 | PPI-2458 | SmallMoleculeDrug |
| ENSG00000111142 | METAP2 | DB07309 | 5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID | SmallMoleculeDrug |
| ENSG00000111142 | METAP2 | DB07313 | 5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID | SmallMoleculeDrug |
| ENSG00000111142 | METAP2 | DB07322 | 2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID | SmallMoleculeDrug |
| ENSG00000111142 | METAP2 | DB07323 | 2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID | SmallMoleculeDrug |
| ENSG00000111142 | METAP2 | DB07377 | N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE | SmallMoleculeDrug |
| ENSG00000111142 | METAP2 | DB07746 | 3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID | SmallMoleculeDrug |
| ENSG00000111142 | METAP2 | DB08633 | TNP-470 | SmallMoleculeDrug |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
| ENSG00000111142 | MAP2 | DB01229 | Paclitaxel | SmallMoleculeDrug | Treat Breast Cancer,Non-Small Cell Lung Cancer,Pancreatic Cancer |
| ENSG00000111142 | MAP2 | DB01248 | Docetaxel | SmallMoleculeDrug | Treat Breast Cancer, Gastroesophageal Junction Cancer,Head and Neck Cancer,Non-Small Cell Lung Cancer,Prostate Cancer,Stomach (Gastric) Cancer |
Top |
Structure and expression level for METAP2 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for METAP2 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for METAP2 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRP | cg11210343 | chr12:95475377 | CGI:chr12:95473808-95474243 | promoter,gene body | 3.01e-01 | 1.75e-01 | 3.36e+00 | 7.92e-04 | 1.49e-03 | 1.26e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for METAP2 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for METAP2 |
| ∗Please access CAeditome for RNA editing annotation. |
Landscape of RNA editing events across multiple cancer types. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| LUAD | METAP2-007 | chr12_95498756_+ | 4.69e-01 | 3.17e-01 | 2.14e+00 | 3.21e-02 | 4.37e-02 | 1.52e-01 |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for METAP2 |
TFs related to METAP2.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | GATA5 | METAP2 | 5.42e+00 | 9.82e-01 | 4.74e+00 | 1.67e-02 | Male-biased |
| ACC | HNF1A | METAP2 | 4.31e+00 | 9.85e-01 | 3.45e+00 | 7.63e-03 | Male-biased |
| ACC | NKX3-1 | METAP2 | 4.42e+00 | 9.84e-01 | 3.63e+00 | 1.04e-02 | Male-biased |
| ACC | ZNF334 | METAP2 | 3.83e+00 | 9.82e-01 | 2.72e+00 | 2.48e-03 | Male-biased |
| ACC | ZNF354B | METAP2 | 4.25e+00 | 9.82e-01 | 3.47e+00 | 1.04e-02 | Male-biased |
| CHOL | SPI1 | METAP2 | 4.08e+00 | 9.85e-01 | 2.95e+00 | 5.10e-03 | Male-biased |
| CHOL | SPIB | METAP2 | 4.08e+00 | 9.83e-01 | 3.02e+00 | 6.86e-03 | Male-biased |
| CHOL | ZNF334 | METAP2 | 4.10e+00 | 9.83e-01 | 3.04e+00 | 6.89e-03 | Male-biased |
| THYM | ZNF334 | METAP2 | 4.14e+00 | 3.84e-03 | 5.07e+00 | 9.93e-01 | Female-biased |
| THYM | ZNF418 | METAP2 | 3.98e+00 | 1.45e-03 | 5.16e+00 | 9.96e-01 | Female-biased |
| THYM | ZNF79 | METAP2 | 4.02e+00 | 5.26e-03 | 4.87e+00 | 9.90e-01 | Female-biased |
| THYM | ZNF879 | METAP2 | 3.64e+00 | 3.29e-03 | 4.61e+00 | 9.90e-01 | Female-biased |
METAP2 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for METAP2 |
RBPs related to ES in METAP2.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| STAD | HNRNPH2 | exon_skip_85931 | 6.81e+00 | 9.84e-01 | 6.05e+00 | 5.12e-04 | Male-biased |
| STAD | QKI | exon_skip_85934 | 1.48e+01 | 9.88e-01 | 1.44e+01 | 1.16e-02 | Male-biased |
| ACC | QKI | exon_skip_85934 | 1.54e+01 | 9.96e-01 | 1.48e+01 | 4.42e-03 | Male-biased |
| LIHC | QKI | exon_skip_85934 | 1.48e+01 | 1.51e-03 | 1.55e+01 | 9.98e-01 | Female-biased |
| COAD | QKI | exon_skip_85934 | 1.53e+01 | 9.99e-01 | 1.46e+01 | 6.92e-04 | Male-biased |
| DLBC | HNRNPH2 | exon_skip_85938 | 6.37e+00 | 3.68e-03 | 6.79e+00 | 9.81e-01 | Female-biased |
| LUAD | HNRNPH2 | exon_skip_85927 | 8.51e+00 | 9.88e-01 | 8.13e+00 | 5.89e-03 | Male-biased |
| CHOL | PCBP2 | exon_skip_85938 | 6.48e+00 | 3.91e-03 | 7.01e+00 | 9.82e-01 | Female-biased |
| KIRP | QKI | exon_skip_85934 | 1.54e+01 | 6.00e-04 | 1.60e+01 | 9.99e-01 | Female-biased |
| BRCA | QKI | exon_skip_85934 | 1.51e+01 | 9.92e-01 | 1.45e+01 | 7.72e-03 | Male-biased |
| ESCA | HNRNPH2 | exon_skip_85938 | 6.59e+00 | 9.82e-01 | 5.86e+00 | 1.64e-03 | Male-biased |
| ESCA | QKI | exon_skip_85934 | 1.43e+01 | 1.11e-03 | 1.51e+01 | 9.99e-01 | Female-biased |
| READ | QKI | exon_skip_85934 | 1.44e+01 | 3.93e-04 | 1.50e+01 | 1.00e+00 | Female-biased |
| MESO | QKI | exon_skip_85934 | 1.50e+01 | 2.73e-04 | 1.57e+01 | 1.00e+00 | Female-biased |
| LGG | HNRNPH2 | exon_skip_85938 | 7.10e+00 | 9.85e-01 | 6.61e+00 | 2.02e-03 | Male-biased |
| GBM | ZFP36 | exon_skip_85924 | 7.54e+00 | 9.83e-01 | 7.16e+00 | 6.31e-03 | Male-biased |
| PAAD | HNRNPH2 | exon_skip_85927 | 8.03e+00 | 6.62e-04 | 8.56e+00 | 9.93e-01 | Female-biased |
| KIRC | QKI | exon_skip_85934 | 1.45e+01 | 4.32e-04 | 1.52e+01 | 1.00e+00 | Female-biased |
| KICH | HNRNPH2 | exon_skip_85927 | 8.33e+00 | 9.84e-01 | 7.99e+00 | 8.51e-03 | Male-biased |
| KICH | QKI | exon_skip_85934 | 1.48e+01 | 1.08e-03 | 1.53e+01 | 9.99e-01 | Female-biased |
| BLCA | QKI | exon_skip_85934 | 1.52e+01 | 4.89e-04 | 1.59e+01 | 9.99e-01 | Female-biased |
| BLCA | ZFP36 | exon_skip_85925 | 7.54e+00 | 9.81e-01 | 7.16e+00 | 9.07e-03 | Male-biased |
METAP2 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs61333525 | chr12:101930225:C:T | - | 0.239786302799145 | 0.00544021353716918 | STAD | Female-baised eQTL |
| rs17026639 | chr12:97200006:A:G | - | 0.419257787541929 | 0.0149244128577143 | STAD | Female-baised eQTL |
| rs11111938 | chr12:104231615:G:A | - | 0.126410441185589 | 0.015179840831374 | STAD | Female-baised eQTL |
| rs17026555 | chr12:97171659:A:T | - | 0.372051745911547 | 0.0247686170573036 | STAD | Female-baised eQTL |
| rs11111921 | chr12:104179726:C:A | - | 0.114605251452263 | 0.0477966794675637 | STAD | Female-baised eQTL |
| rs2647876 | chr12:102685654:C:T | - | 0.0924696743129901 | 0.0230780129921804 | LUAD | Female-baised eQTL |
| rs73383461 | chr12:104935427:C:T | - | -0.111868349273065 | 0.0438019670738119 | LUAD | Female-baised eQTL |
| rs3923753 | chr12:104931129:T:C | - | -0.111507905786128 | 0.0452243895859656 | LUAD | Female-baised eQTL |
| rs74793671 | chr12:97281108:T:G | - | 0.100941717343763 | 0.0485519843007671 | LUAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs61935039 | chr12:92069706:T:C | - | 0.164097866136172 | 0.0321146387219034 | SARC | Male-baised eQTL |
| rs11108328 | chr12:95908139:G:A | - | 0.287288813074814 | 0.0427795091365167 | SARC | Male-baised eQTL |
| rs73231439 | chr12:95914918:C:T | - | 0.287288813074814 | 0.0427795091365167 | SARC | Male-baised eQTL |
| rs73231440 | chr12:95914945:T:C | - | 0.287288813074814 | 0.0427795091365167 | SARC | Male-baised eQTL |
| rs9668340 | chr12:95901564:T:G | - | 0.286872870547272 | 0.0438139677387002 | SARC | Male-baised eQTL |
| rs11108329 | chr12:95908141:G:C | - | 0.285418695114849 | 0.0468035320151542 | SARC | Male-baised eQTL |
| rs11611877 | chr12:95910546:T:C | - | 0.285418695114849 | 0.0468035320151542 | SARC | Male-baised eQTL |
| rs73177980 | chr12:104109705:A:G | - | 0.0904438407721108 | 0.025696763930118 | BLCA | Male-baised eQTL |
| rs140441459 | chr12:104113958:C:T | - | 0.0904438407721108 | 0.025696763930118 | BLCA | Male-baised eQTL |
| rs73177982 | chr12:104118229:A:G | - | 0.0830715484903672 | 0.0427899444816534 | BLCA | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of METAP2 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |